Wednesday, October 5, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

WHITE PLAINS, N.Y. - Directors of Mela Sciences dumped $79 million of their shares at inflated prices by misrepresenting prospects for the company's MelaFind device, which supposedly could detect melanomas, shareholders claim in Westchester County Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.